Poikiloderma vasculare atrophicans
Poikiloderma vasculare atrophicans (PVA) is a rare dermatological condition characterized by skin atrophy, telangiectasia, and hyperpigmentation. It is a form of poikiloderma, a group of conditions that involve changes in skin color and texture.
Etiology[edit | edit source]
The exact cause of PVA is unknown. However, it is believed to be associated with various underlying conditions such as cutaneous T-cell lymphoma, dermatomyositis, and scleroderma. Some researchers suggest that it may be an autoimmune response, but this theory is not universally accepted.
Symptoms[edit | edit source]
The primary symptoms of PVA include changes in skin color (hyperpigmentation and hypopigmentation), skin atrophy, and telangiectasia. These changes typically occur on the neck, chest, and limbs. The skin may also become dry and scaly. In some cases, patients may experience itching or discomfort.
Diagnosis[edit | edit source]
Diagnosis of PVA is primarily based on clinical examination and the patient's medical history. Dermoscopy and skin biopsy may be used to confirm the diagnosis and rule out other conditions.
Treatment[edit | edit source]
There is currently no cure for PVA. Treatment is primarily aimed at managing symptoms and preventing complications. This may include the use of topical corticosteroids, photoprotection, and emollients. In severe cases, immunomodulatory therapy may be considered.
Prognosis[edit | edit source]
The prognosis for PVA varies depending on the underlying cause and the severity of the condition. With appropriate management, most patients can lead a normal life. However, the condition can cause significant cosmetic concerns and may impact the patient's quality of life.
See also[edit | edit source]
This article is a dermatology stub. You can help WikiMD by expanding it!
</noinclude>
This rare disease-related article is a stub. You can help WikiMD by expanding it.
Poikiloderma vasculare atrophicans[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD